pyranoprofen has been researched along with Gout in 1 studies
pyranoprofen: RN given refers to unlabled parent cpd; structure given in first source
Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terasawa, M | 1 |
| Aratani, H | 1 |
| Iwahisa, Y | 1 |
| Imayoshi, T | 1 |
| Maruyama, Y | 1 |
1 other study available for pyranoprofen and Gout
| Article | Year |
|---|---|
[Effect of pranoprofen on sodium urate crystal-induced inflammation].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzopyrans; Colchicine; Dogs; Female; | 1987 |